Fuse Diagnostics, a developer of next-generation molecular diagnostics for point-of-need testing, has raised £1 million in a round led by The FSE Group.
DiagnosticsFuse Diagnostics, a developer of next-generation molecular diagnostics for point-of-need testing, has raised £1 million in a round led by The FSE Group.
DiagnosticsMedovate and MEB Technologies are merging, combining their staff and operations under the Medovate name.
M&APegasus Care has acquired Parkside Care, which comprises three homes in Northeast England.
M&A